Pharmaceutical Drug Development Services Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2016-2021 and Forecast 2022-2028

$ PRICE - $ 3,000.00$ 8,900.00

Pharmaceutical Drug Development Services Market: By Molecule Type (Biological Solutions, Small Molecule Solutions, and Biosimilar Development Solutions), By Phase (Pre-Clinical, Phase I, Phase II, Phase III), By Specialty Area (Cardiovascular, Diabetes, Endocrinology, Nephrology, Immuno-Oncology, Infectious Diseases, Oncology, Rare Diseases and Orphan Drugs, Pediatrics, Neuroscience, and Others) and Geography

 

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

Pharmaceutical Drug Development Services Market size was valued at USD x million in 2021 and is expected to reach USD x million by 2028, at a CAGR of x% during the forecast period 2022 to 2028. Owing to increasing stringent regulatory framework and cost of drug development for products coupled with focus of the pharmaceutical and biopharmaceutical companies on CROs and CDMOs to reduce the cost of the development of the product are the major factors that are driving the growth of the pharmaceutical drug development services market. Moreover, Identification of lead, drug discovery, clinical trial monitoring and regulatory compliance fuels the growth of the market over the forecast period. This report studies global pharmaceutical drug development services market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, global pharmaceutical drug development services market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global pharmaceutical drug development services market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities).

Pharmaceutical Drug Development Services Market

MARKET SUMMARY
-
x%
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– x%
  • Largest Market– Asia-Pacific
  • Fastest Growing Market– North-America

Pharmaceutical Drug Development Services Market

  • The global pharmaceutical drug development services market report gives comprehensive outlook on pharmaceutical drug development services across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa.
  • The report on global pharmaceutical drug development services market gives historical, current, and future market sizes (US$ Mn) on the basis of molecule, phase, specialty area, and region.
  • Key stakeholders of the global pharmaceutical drug development services market report include suppliers, manufacturers, marketers, policy makers, and service providers engaged in global pharmaceutical drug development services products.
Key Players
  • Syneos Health
  • Parexel
  • IQVIA
  • Celerion
  • Piramal Pharma solutions
Pharmaceutical Drug Development Services Market

DRIVERS AND RESTRAINTS

The pharmaceutical and biopharmaceutical companies are focusing on the strategic collaborations with the drug development service providers to avoid the stringent regulatory policies and to reduce the cost of the drug development and this is the trend that was being observed in the market. For instance, in June 2018, Syneos Health and Elligo Health Research entered into a strategic collaboration to mobilize a system of accelerated research to reach real-world patients.


North-America Got Significant Share

Pharmaceutical Drug Development Services Market

North America accounted for larger revenue share in global pharmaceutical drug development services market with significant CAGR owing to the presence of large number of prominent market players in the region and increasing adoption of eClinical solutions and rise in the use of interactive response technology in adaptive clinical trials. Asia Pacific region is expected to grow at highest CAGR owing to more number of CDMOs and CROs presence in the region.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Findings of the Report

  • Global pharmaceutical drug development services market expanding at significant CAGR over 2019 to 2025 owing to increasing demand for outsourcing to the CROs and CDMOs for drug development services.
  • Based on specialty area, oncology segment of pharmaceutical drug development services accounted for larger market revenue share in 2018 and projected gain market revenue share over the forecast period
  • Players focusing on collaboration strategies with the government to retain market position in global pharmaceutical drug development services market

Key

Features of the Report

Pharmaceutical Drug Development Services Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.


Report

Table Of Content

  1. Executive Summary
  2. Global Pharmaceutical Drug Development Services Market Introduction

2.1. Global Pharmaceutical Drug Development Services Market – Taxonomy

2.2. Global Pharmaceutical Drug Development Services Market –Definitions

2.2.1. By Molecule

2.2.2. By Phase

2.2.3. By Specialty Type

  1. Global Pharmaceutical Drug Development Services Market Dynamics

3.1. Drivers

3.2. Restraints

3.3. Opportunities/Unmet Needs of the Market

3.4. Trends

3.5. Global Pharmaceutical Drug Development Services Market Dynamics – Factors Impact Analysis

  1. Global Pharmaceutical Drug Development Services Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025

4.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)

4.3. Market Opportunity Analysis

  1. Global Pharmaceutical Drug Development Services Market Forecast, By Molecule, 2014 – 2018 and Forecast, 2019 – 2025

5.1. Biologic Solutions

5.1.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.1.3. Market Opportunity Analysis

5.2. Small Molecule Solutions

5.2.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.2.3. Market Opportunity Analysis

5.3. Biosimilar Development Solutions

5.3.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.3.3. Market Opportunity Analysis

  1. Global Pharmaceutical Drug Development Services Market Forecast, By Phase, 2014 – 2018 and Forecast, 2019 – 2025

6.1. Pre-Clinical

6.1.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.1.3. Market Opportunity Analysis

6.2. Phase 1

6.2.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.2.3. Market Opportunity Analysis

6.3. Phase II

6.3.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.3.3. Market Opportunity Analysis

6.4. Phase III

6.4.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.4.3. Market Opportunity Analysis

  1. Global Pharmaceutical Drug Development Services Market Forecast, By Specialty Type, 2014 – 2018 and Forecast, 2019 – 2025

7.1. Cardiovascular

7.1.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.1.3. Market Opportunity Analysis

7.2. Diabetes, Endocrinology, and Nephrology

7.2.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.2.3. Market Opportunity Analysis

7.3. Immuno-Oncology

7.3.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.3.3. Market Opportunity Analysis

7.4. Infectious Diseases

7.4.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.4.3. Market Opportunity Analysis

7.5. Oncology

7.5.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.5.3. Market Opportunity Analysis

7.6. Rare Diseases and Orphan Drugs

7.6.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

7.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.6.3. Market Opportunity Analysis

7.7. Pediatrics

7.7.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

7.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.7.3. Market Opportunity Analysis

7.8. Neuroscience

7.8.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

7.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.8.3. Market Opportunity Analysis

7.9. Others

7.9.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

7.9.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.9.3. Market Opportunity Analysis

  1. Global Pharmaceutical Drug Development Services Market Forecast, By Region, 2014 – 2018 and Forecast, 2019 – 2025

8.1. North America

8.1.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.1.3. Market Opportunity Analysis

8.2. Europe

8.2.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.2.3. Market Opportunity Analysis

8.3. Asia Pacific

8.3.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.3.3. Market Opportunity Analysis

8.4. Latin America

8.4.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.4.3. Market Opportunity Analysis

8.5. The Middle East & Africa

8.5.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.5.3. Market Opportunity Analysis

8.6. Global Pharmaceutical Drug Development Services Market – Opportunity Analysis Index, By Product, By Application, By End User, and Region, 2019 – 2025

  1. North America Pharmaceutical Drug Development Services Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025

9.1. Molecule Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

9.1.1. Biologic Solutions

9.1.2. Small Molecule Solutions

9.1.3. Biosimilar Development Solutions

9.2. Phase Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

9.2.1. Pre-Clinical

9.2.2. Phase I

9.2.3. Phase II

9.2.4. Phase III

9.3. Specialty Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

9.3.1. Cardiovascular

9.3.2. Diabetes, Endocrinology, and Nephrology

9.3.3. Immuno-Oncology

9.3.4. Infectious Diseases

9.3.5. Oncology

9.3.6. Rare Diseases and Orphan Drugs

9.3.7. Pediatrics

9.3.8. Neuroscience

9.3.9. Others

9.4. Country Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

9.4.1. U.S.

9.4.2. Canada

9.5. North America Pharmaceutical Drug Development Services Market – Opportunity Analysis Index, By Molecule Type, By Phase, By Specialty Type, and Country, 2019 – 2025

9.6. North America Pharmaceutical Drug Development Services Market Dynamics – Trends

  1. Europe Pharmaceutical Drug Development Services Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025

10.1. Molecule Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

10.1.1. Biologic Solutions

10.1.2. Small Molecule Solutions

10.1.3. Biosimilar Development Solutions

10.2. Phase Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

10.2.1. Pre-Clinical

10.2.2. Phase I

10.2.3. Phase II

10.2.4. Phase III

10.3. Specialty Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

10.3.1. Cardiovascular

10.3.2. Diabetes, Endocrinology, and Nephrology

10.3.3. Immuno-Oncology

10.3.4. Infectious Diseases

10.3.5. Oncology

10.3.6. Rare Diseases and Orphan Drugs

10.3.7. Pediatrics

10.3.8. Neuroscience

10.3.9. Others

10.4. Country Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

10.4.1. U.K.

10.4.2. Germany

10.4.3. France

10.4.4. Italy

10.4.5. Spain

10.4.6. Russia

10.4.7. Rest of Europe

10.5. Europe Pharmaceutical Drug Development Services Market – Opportunity Analysis Index, By Molecule, By Phase, By Specialty Type, and Country, 2019 – 2025

10.6. Europe Pharmaceutical Drug Development Services Market Dynamics – Trends

  1. Asia Pacific Pharmaceutical Drug Development Services Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025

11.1. Molecule Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

11.1.1. Biologic Solutions

11.1.2. Small Molecule Solutions

11.1.3. Biosimilar Development Solutions

11.2. Phase Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

11.2.1. Pre-Clinical

11.2.2. Phase I

11.2.3. Phase II

11.2.4. Phase III

11.3. Specialty Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

11.3.1. Cardiovascular

11.3.2. Diabetes, Endocrinology, and Nephrology

11.3.3. Immuno-Oncology

11.3.4. Infectious Diseases

11.3.5. Oncology

11.3.6. Rare Diseases and Orphan Drugs

11.3.7. Pediatrics

11.3.8. Neuroscience

11.3.9. Others

11.4. Country Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

11.4.1. China

11.4.2. Japan

11.4.3. India

11.4.4. ASEAN Counties

11.4.5. Philippines

11.4.6. Rest of Asia Pacific

11.5. Asia Pacific Pharmaceutical Drug Development Services Market – Opportunity Analysis Index, By Molecule, By Phase, By Specialty Type, and Country, 2019 – 2025

11.6. Asia Pacific Pharmaceutical Drug Development Services Market Dynamics – Trends

  1. Latin America Pharmaceutical Drug Development Services Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025

12.1. Molecule Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

12.1.1. Biologic Solutions

12.1.2. Small Molecule Solutions

12.1.3. Biosimilar Development Solutions

12.2. Phase Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

12.2.1. Pre-Clinical

12.2.2. Phase I

12.2.3. Phase II

12.2.4. Phase III

12.3. Specialty Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

12.3.1. Cardiovascular

12.3.2. Diabetes, Endocrinology, and Nephrology

12.3.3. Immuno-Oncology

12.3.4. Infectious Diseases

12.3.5. Oncology

12.3.6. Rare Diseases and Orphan Drugs

12.3.7. Pediatrics

12.3.8. Neuroscience

12.3.9. Others

12.4. Country Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

12.4.1. Mexico

12.4.2. Brazil

12.4.3. Argentina

12.4.4. Chile

12.4.5. Rest of Latin America

12.5. Latin America Pharmaceutical Drug Development Services Market – Opportunity Analysis Index, By Molecule, By Phase, By Specialty Type, and Country, 2019 – 2025

12.6. Latin America Pharmaceutical Drug Development Services Market Dynamics – Trends

  1. Middle East and Africa Pharmaceutical Drug Development Services Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025

13.1. Molecule Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

13.1.1. Biologic Solutions

13.1.2. Small Molecule Solutions

13.1.3. Biosimilar Development Solutions

13.2. Phase Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

13.2.1. Pre-Clinical

13.2.2. Phase I

13.2.3. Phase II

13.2.4. Phase III

13.3. Specialty Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

13.3.1. Cardiovascular

13.3.2. Diabetes, Endocrinology, and Nephrology

13.3.3. Immuno-Oncology

13.3.4. Infectious Diseases

13.3.5. Oncology

13.3.6. Rare Diseases and Orphan Drugs

13.3.7. Pediatrics

13.3.8. Neuroscience

13.3.9. Others

13.4. Country Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

13.4.1. GCC Countries

13.4.2. South Africa

13.4.3. Saudi Arabia

13.4.4. Turkey

13.4.5. Rest of MEA

13.5. Middle East and Africa Pharmaceutical Drug Development Services Market – Opportunity Analysis Index, By Molecule, By Phase, By Specialty Type, and Country, 2019 – 2025

13.6. Middle East and Africa Pharmaceutical Drug Development Services Market Dynamics – Trends

  1. Competition Landscape

14.1. Strategic Dashboard of Top Market Players

14.2. Company Profiles (Introduction, Financial Analysis, Key Developments, Strategies, and SWOT Analysis)

14.2.1. Syneos Health

14.2.2. Parexel

14.2.3. IQVIA

14.2.4. Celerion

14.2.5. Piramal Pharma solutions

14.2.6. Catalent, Inc.

14.2.7. Patheon – a Thermo Fisher Company

14.2.8. Pharmaceutical Product Development, LLC.

14.2.9. Covance Inc.

14.2.10. MEDPACE

  1. Research Methodology
  2. Key Assumptions and Acronyms

Report

Company Profile

  • Syneos Health
  • Parexel
  • IQVIA
  • Celerion
  • Piramal Pharma solutions
  • Catalent, Inc.
  • Patheon – a Thermo Fisher Company
  • Pharmaceutical Product Development, LLC.
  • Covance Inc.
  • MEDPACE

Description

Pharmaceutical Drug Development Services Market size was valued at USD x million in 2021 and is expected to reach USD x million by 2028, at a CAGR of x% during the forecast period 2022 to 2028. Owing to increasing stringent regulatory framework and cost of drug development for products coupled with focus of the pharmaceutical and biopharmaceutical companies on CROs and CDMOs to reduce the cost of the development of the product are the major factors that are driving the growth of the pharmaceutical drug development services market. Moreover, Identification of lead, drug discovery, clinical trial monitoring and regulatory compliance fuels the growth of the market over the forecast period. This report studies global pharmaceutical drug development services market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, global pharmaceutical drug development services market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global pharmaceutical drug development services market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities).

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX